Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Advertise | Contacts | Login 
  Users Online: 1249 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Novel Agents for the Management of Endocrine Resistant Breast Cancer
Sonya Reid-Lawrence,Ingrid A. Mayer
Current Breast Cancer Reports.2018;10(4)274
[DOI]
2Real-world effectiveness of fulvestrant monotherapy as first endocrine treatment in patients with metastatic breast cancer
Karen E. Skinner,Temitope Olufade,Mark S. Walker,Lee S. Schwartzberg
The Breast Journal.2019;10(4)274
[DOI]
3Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay
Troels Dreier Christensen,Anna Sofie Kappel Buhl,Ib Jarle Christensen,Ida Kappel Buhl,Eva Balslev,Ann S. Knoop,Hella Danø,Vesna Glavicic,Adam Luczak,Sven Tyge Langkjer,Søren Linnet,Erik Hugger Jakobsen,Jurij Bogovic,Bent Ejlertsen,Annie Rasmussen,Anker Hansen,Steen Knudsen,Peter Buhl Jensen,Dorte Nielsen
Breast Cancer.2019;10(4)274
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal